Pancreatic cancer

被引：34

作者：

Cohen S.J. ^{[1
]}

Pinover W.H. ^{[2
]}

Watson J.C. ^{[3
]}

Meropol N.J. ^{[1
]}

机构：

[1] Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, 19111

[2] Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, 19111

[3] Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, 19111

来源：

Current Treatment Options in Oncology | 2000年 / 1卷 / 5期

关键词：

Pancreatic Cancer; Gemcitabine; Pancreatic Carcinoma; Pancreatic Adenocarcinoma; Main Drug Interaction;

D O I：

10.1007/s11864-000-0065-2

中图分类号：

学科分类号：

摘要：

Optimal therapy for pancreatic adenocarcinoma requires surgical removal with tumor-free margins. Superior outcomes have been reported for high-volume centers incorporating a multidisciplinary approach. Postoperative ("adjuvant") chemotherapy and radiation should be considered in patients with successfully resected primary tumors. Combined modality treatment with chemotherapy and radiation should be considered for locally advanced, unresectable tumors. Gemcitabine can provide symptom relief and a modest improvement in survival for patients with metastatic disease. Strict attention to relief of symptoms such as pain, depression, anorexia/cachexia, and jaundice is essential in all patients with pancreatic cancer. All patients with pancreatic cancer should be encouraged to enter clinical trials of new therapies, given that long-term survival for all stages remains poor.

引用

页码：375 / 386

页数：11

共 123 条

[1] Greenlee RT(2000)Cancer statistics, 2000 CA Cancer J Clin 50 7-33
[2] Murray T(1999)Pancreatico-biliary malignancy: prevalence and risk factors Ann Oncol 10 S1-S3
[3] Bolden S(1994)Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma Nat Genet 8 27-32
[4] Wingo PA(1995)Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumorsuppressor gene N Engl J Med 333 975-977
[5] Lowenfels AB(1996)DPC4 gene in various tumor types Cancer Res 56 2527-2530
[6] Maisonneuve P(1997)Tumor- suppressive pathways in pancreatic carcinoma Cancer Res 57 1731-1734
[7] Caldas C(1996)Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas Cancer Res 56 5360-5364
[8] Hahn SA(2000)Progression model for pancreatic cancer Clin Cancer Res 6 2969-2972
[9] da Costa LT(1999)The standard diagnostic work-up and surgical treatment of pancreatic head tumours Eur J Surg Oncol 25 113-123
[10] Whelan AJ(1997)TNM staging of pancreatic carcinoma using helical CT Am J Roentgenol 169 459-464

← 1 2 3 4 5 6 7 8 9 10 →